共 50 条
- [44] Durable clinical benefit following paclitaxel-eluting stent (TAXUS™) deployment on the outcome of patients with very long coronary lesions:: Multicenter registry 2-year results AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 184H - 185H
- [50] 5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents Final Results From the SPIRIT III Trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (12) : 1263 - 1266